Emily Wagner

Emily Wagner

Auto-generated profile, based on publicly available information

Emily Wagner

McKelvey School of Engineering, Washington University in St. Louis 1 Department of Biomedical Engineering St. Louis, MO

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2021 in Journal of General Physiology
Verified
Journal Article
Open access
PDF file
MLMaxime Lorenzini
Maxime Lorenzini
SBSophie Burel
Sophie Burel
ALAdrien Lesage
Adrien Lesage
EWEmily Wagner
Emily Wagner
CCCamille Charrière
Camille Charrière
CMCéline Marionneau
Céline Marionneau
Phosphorylation of the voltage-gated Na+ (NaV) channel NaV1.5 regulates cardiac excitability, yet the phosphorylation sites regulating its function and the underlying mechanisms remain largely unknown. Using a systematic, quantitative phosphoproteomic approach, we analyzed NaV1.5 channel complexes purified from nonfailing and failing mouse left ventricles, and we identified 42 phosphorylation sites on NaV1.5. Most sites are clustered, and three of these clusters are highly phosphorylated. Analyses of phosphosilent and phosphomimetic NaV1.5 mutants revealed the roles of three phosphosites in regulating NaV1.5 channel expression and gating. The phosphorylated serines S664 and S667 regulate the voltage dependence of channel activation in a cumulative manner, whereas the nearby S671, the phosphorylation of which is increased in failing hearts, regulates cell surface NaV1.5 expression and peak Na+ current. No additional roles could be assigned to the other clusters of phosphosites. Taken together, our results demonstrate that ventricular NaV1.5 is highly phosphorylated and that the phosphorylation-dependent regulation of NaV1.5 channels is highly complex, site specific, and dynamic.

4 September 2025 in Journal of General Physiology
Verified
Journal Article
Closed access
EWEmily Wagner
Emily Wagner
MMMartina Marras
Martina Marras
SKShashi Kumar
Shashi Kumar
JKJacob Kelley
Jacob Kelley
KRKiersten M. Ruff
Kiersten M. Ruff
JSJonathan Silva
Jonathan Silva
The cardiac voltage-gated sodium channel, Nav1.5, initiates the cardiac action potential. Its dysfunction can lead to dangerous arrhythmias, sudden cardiac arrest, and death. The functional Nav1.5 core consists of four homologous repeats (I, II, III, and IV), each formed from a voltage sensing and a pore domain. The channel also contains three cytoplasmic linkers (I–II, II–III, and III–IV). While Nav1.5 structures have been published, the I–II and II–III linkers have remained absent, are predicted to be disordered, and their functional role is not well understood. We divided the I–II linker into eight regions ranging in size from 32 to 52 residues, chosen based on their distinct properties. Since these regions had unique sequence properties, we hypothesized that they may have distinct effects on channel function. We tested this hypothesis with experiments with individual Nav1.5 constructs with each region deleted. These deletions had small effects on channel gating, though two (430–457del and 556–607del) reduced peak current. Phylogenetic analysis of the I–II linker revealed five prolines (P627, P628, P637, P640, and P648) that were conserved in mammals but absent from the Xenopus sequence. We created mutant channels, where these were replaced with their Xenopus counterparts. The only mutation that had a significant effect on channel gating was P627S, which depolarized channel activation (10.13 ± 2.28 mV). Neither a phosphosilent (P627A) nor a phosphomimetic (P627E) mutation had a significant effect, suggesting that either phosphorylation or another specific serine property is required. Since deletion of large regions had little effect on channel gating while a point mutation had a conspicuous impact, the I–II linker role may be to facilitate interactions with other proteins. Variants may have a larger impact if they create or disrupt these interactions, which may be key in evaluating the pathogenicity of variants.